Auf dieser Seite
01ZTS Preis
02Momentaufnahme
03Chart
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
ZTS Klasse A Zoetis Inc. Class A Common Stock
NYSE · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$69,69
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$68,7852-Wochen-Tief
$148,3052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$28.86B
P/E (TTM)
11.5
EPS (TTM)
$6.07
Umsatz (TTM)
$9.52B
Ihre Abzeichen
52W-Spanne
$69–$148
Analystenbewertung
HOLD
Kursziel
$96
P/E
11.5
ROE
64.4%
Nettogewinnmarge
27.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ZTS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$69.69
Marktkapitalisierung (MRQ)
$28.86B
P/E (TTM)
11.5
EPS (TTM)
$6.07
Umsatz (TTM)
$9.52B
ROE (TTM)
64.4%
Verschuldungsgrad (MRQ)
2.9
52W-Spanne
$69–$148
ZTS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Zoetis Inc. Class A Common Stock Unternehmensübersicht von Wikipedia
Zoetis, Inc. ist ein US-amerikanischer Hersteller von Tierarzneimitteln und Impfstoffen für Haus- und Nutztiere. Zwei Drittel des Umsatzes entfallen auf den Bereich Nutztiere. Gemessen am Gesamtumsatz der Branche war Zoetis 2012 mit einem Anteil von rund 20 % Weltmarktführer. Das 1952 gegründete Unternehmen hat seinen Sitz in Parsippany, New Jersey.
Bis 2013 war Zoetis eine Tochterfirma des Pharmakonzerns Pfizer. Anfang 2013 brachte Pfizer seine Tiergesundheitssparte an die New Yorker Börse, damals der größte Börsengang seit Facebook. Seit Pfizer im Juni 2013 auch seinen restlichen Anteil von 83 % verkaufte, ist Zoetis unabhängig und wurde in den Börsenindex S&P 500 aufgenommen.
2016 wurde der Unternehmenssitz von Florham Park nach Parsippany-Troy Hills Township (New Jersey) verlegt.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealthcare
BranchePharmaceuticals
Mitarbeiter14.500
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$9.47B2016-12-31 → 2025-12-31
EPS$6.022016-12-31 → 2025-12-31
Freier Cashflow$2.28B2016-12-31 → 2025-12-31
Nettogewinnmarge27.5%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ZTS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 11.55-Jahres-Durchschnitt ≈35.9 | ≈35.9 | 31.0 | Unterbewertet | |
| P/S (TTM) | 3.05-Jahres-Durchschnitt ≈9.5 | ≈9.5 | · | · | |
| K/B (MRQ) | 9.25-Jahres-Durchschnitt ≈18.1 | ≈18.1 | · | · | |
| Kurs / FCF (TTM) | 12.25-Jahres-Durchschnitt ≈45.7 | ≈45.7 | · | · | |
| Kurs / Cashflow (TTM) | 10.05-Jahres-Durchschnitt ≈33.9 | ≈33.9 | · | · | |
| EV / Umsatz (TTM) | 3.8 | · | · | · | |
| EV / FCF (TTM) | 15.3 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 12.95-Jahres-Durchschnitt ≈180.4 | ≈180.4 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈1.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ZTS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| EBITDA Margin (EBITDA-Marge) | 5.1%5-Jahres-Durchschnitt ≈5.6% | ≈5.6% | 8.3% | Schwach | |
| Vorgewinnmarge (TTM) | 34.4%5-Jahres-Durchschnitt ≈33.7% | ≈33.7% | 15.0% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 27.5%5-Jahres-Durchschnitt ≈27.0% | ≈27.0% | 10.4% | Spitzenklasse | |
| ROA (TTM) | 17.7%5-Jahres-Durchschnitt ≈16.2% | ≈16.2% | 9.8% | Spitzenklasse | |
| ROE (TTM) | 64.4%5-Jahres-Durchschnitt ≈52.6% | ≈52.6% | 25.3% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ZTS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 2.95-Jahres-Durchschnitt ≈1.7 | ≈1.7 | 0.9 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 3.15-Jahres-Durchschnitt ≈2.9 | ≈2.9 | 1.6 | Starke Liquidität | |
| Quick Ratio (MRQ) | 1.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.8 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 2.95-Jahres-Durchschnitt ≈1.6 | ≈1.6 | 0.9 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ZTS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 2.3%5-Jahres-Durchschnitt ≈7.3% | ≈7.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.4%5-Jahres-Durchschnitt ≈6.7% | ≈6.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 7.2% | · | · | · | |
| EPS YoY (EPS VjV) | 10.1%5-Jahres-Durchschnitt ≈12.2% | ≈12.2% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 7.5%5-Jahres-Durchschnitt ≈10.5% | ≈10.5% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 10.3%5-Jahres-Durchschnitt ≈11.0% | ≈11.0% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 12.0% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 8.1%5-Jahres-Durchschnitt ≈9.2% | ≈9.2% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 10.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ZTS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.5 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.15-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.5 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 6.55-Jahres-Durchschnitt ≈6.9 | ≈6.9 | 5.6 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$652.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Annualisierte Auszahlung≈$2.12
5J Div CAGR≈20.1%
Wachstumsphase≈11
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Jul 20, 2026 | $0,53 | USD | ≈2.7% |
| Apr 20, 2026 | $0,53 | USD | ≈1.7% |
| Jan 20, 2026 | $0,53 | USD | ≈1.6% |
| Okt 31, 2025 | $0,50 | USD | ≈1.4% |
| Jul 18, 2025 | $0,50 | USD | ≈1.3% |
| Apr 21, 2025 | $0,50 | USD | ≈1.3% |
| Jan 21, 2025 | $0,50 | USD | ≈1.1% |
| Okt 31, 2024 | $0,43 | USD | ≈0.97% |
| Jul 18, 2024 | $0,43 | USD | ≈0.93% |
| Apr 18, 2024 | $0,43 | USD | ≈1.1% |
| Jan 18, 2024 | $0,43 | USD | ≈0.82% |
| Okt 31, 2023 | $0,38 | USD | ≈0.96% |
| Jul 20, 2023 | $0,38 | USD | ≈0.84% |
| Apr 20, 2023 | $0,38 | USD | ≈0.80% |
| Jan 19, 2023 | $0,38 | USD | ≈0.83% |
| Okt 31, 2022 | $0,33 | USD | ≈0.86% |
| Jul 20, 2022 | $0,33 | USD | ≈0.70% |
| Apr 20, 2022 | $0,33 | USD | ≈0.61% |
| Jan 19, 2022 | $0,33 | USD | ≈0.54% |
| Okt 28, 2021 | $0,25 | USD | ≈0.47% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.5%
Nächster Bericht
Nov 05, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $1.87 | $1.87 | -0.22% |
| 31. März 2026 | $1.53 | $1.63 | -6.2% | |
| 31. Dezember 2025 | $1.48 | $1.42 | 4.5% | |
| 30. September 2025 | $1.70 | $1.64 | 3.8% | |
| 30. Juni 2025 | $1.76 | $1.63 | 7.8% | |
| 31. März 2025 | $1.48 | $1.41 | 5.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Cost of Revenue | $2.67B | $2.72B | $2.56B | $2.45B | $2.30B | $2.06B | $1.99B | $1.91B | $1.77B | $1.67B | $1.74B | $1.72B | |
| SG&A Expense | $2.38B | $2.32B | $2.15B | $2.01B | $2.00B | $1.73B | $1.64B | $1.48B | $1.33B | $1.36B | $1.53B | $1.64B | |
| Interest Expense | $222M | $225M | $239M | $221M | $224M | $231M | $223M | $206M | $175M | $166M | $124M | $117M | |
| Other Non-op | $-6M | $-4M | $-2M | $14M | $-4M | $-5M | $0 | $15M | $1M | $2M | $5M | $-3M | |
| Pretax Income | $3.36B | $3.13B | $2.94B | $2.66B | $2.49B | $2.00B | $1.80B | $1.69B | $1.52B | $1.23B | $545M | $820M | |
| Income Tax | $687M | $637M | $596M | $545M | $454M | $360M | $301M | $266M | $663M | $409M | $206M | $233M | |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 | $3.44 | $3.14 | $2.96 | $1.76 | $1.66 | $0.68 | $1.16 | |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 | |
| Shares (Basic) | 443,443,000 | 454,200,000 | 461,172,000 | 468,891,000 | 474,348,000 | 475,502,000 | 478,128,000 | 483,063,000 | 489,918,000 | 495,715,000 | 499,707,000 | 501,055,000 | |
| Shares (Diluted) | 443,835,000 | 454,848,000 | 462,269,000 | 470,385,000 | 476,717,000 | 478,569,000 | 481,787,000 | 486,898,000 | 493,161,000 | 498,225,000 | 502,019,000 | 502,025,000 | |
| EBITDA | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.45B | $1.99B | $2.04B | $3.58B | $3.48B | $3.60B | $1.93B | $1.60B | $1.56B | $727M | $1.15B | $882M | |
| Short-term Investments | $0 | · | · | · | · | · | $0 | $99M | $0 | · | · | · | |
| Receivables | $1.41B | $1.32B | $1.30B | $1.22B | $1.13B | $1.01B | $1.09B | $1.04B | $998M | $913M | $937M | $980M | |
| Inventory | $2.46B | $2.31B | $2.56B | $2.35B | $1.92B | $1.63B | $1.41B | $1.39B | $1.43B | $1.50B | $1.47B | $1.29B | |
| Other Current Assets | $450M | $377M | $434M | $365M | $389M | $366M | $318M | $271M | $228M | $248M | $201M | $205M | |
| Current Assets | $6.77B | $5.99B | $6.34B | $7.51B | $6.93B | $6.61B | $4.75B | $4.40B | $4.22B | $3.39B | $3.83B | $3.46B | |
| PP&E (Net) | $3.69B | $3.39B | $3.20B | $2.75B | $2.42B | $2.20B | $1.94B | $1.66B | $1.44B | $1.38B | $1.31B | $1.32B | |
| PP&E (Gross) | $6.61B | $6.03B | $5.80B | $5.05B | $4.49B | $4.15B | $3.68B | $3.26B | $2.91B | $2.74B | $2.52B | $2.46B | |
| Accum. Depreciation | $2.94B | $2.63B | $2.59B | $2.30B | $2.07B | $1.95B | $1.74B | $1.60B | $1.47B | $1.36B | $1.21B | $1.15B | |
| Goodwill | $2.77B | $2.72B | $2.76B | $2.75B | $2.68B | $2.69B | $2.59B | $2.52B | $1.51B | $1.48B | $1.46B | $976M | |
| Intangibles | $998M | $1.13B | $1.34B | $1.38B | $1.47B | $1.71B | $1.89B | $2.05B | $1.27B | $1.23B | $1.19B | $727M | |
| Other Non-current Assets | $327M | $250M | $206M | $147M | $111M | $106M | $98M | $94M | $75M | $73M | $49M | $48M | |
| Total Assets | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Accounts Payable | $445M | $433M | $411M | $405M | $436M | $457M | $301M | $313M | $261M | $265M | $293M | $290M | |
| Accrued Liabilities | $852M | $746M | $683M | $682M | $710M | $556M | $543M | $487M | $432M | $464M | $676M | $475M | |
| Short-term Debt | $0 | $0 | $3M | $2M | $0 | $4M | $0 | $9M | $0 | $0 | $0 | $0 | |
| Current Liabilities | $2.17B | $3.41B | $1.89B | $3.17B | $1.80B | $2.17B | $1.81B | $1.22B | $1.09B | $1.12B | $1.78B | $1.09B | |
| Capital Leases | $197M | $174M | $188M | $186M | $151M | $163M | $164M | $0 | · | · | · | · | |
| Deferred Tax | $137M | $167M | $146M | $142M | $320M | $378M | $434M | $474M | $380M | $244M | $264M | $277M | |
| Other Non-current Liabilities | $250M | $222M | $237M | $217M | $239M | $270M | $229M | $187M | $201M | $248M | $251M | $207M | |
| Total Liabilities | $12.07B | $9.47B | $9.29B | $10.52B | $9.36B | $9.84B | $8.84B | $8.59B | $6.80B | $6.15B | $6.82B | $5.25B | |
| Long-term Debt | $9.04B | $6.57B | $6.56B | $7.90B | $6.59B | $7.20B | $6.45B | $6.44B | $4.95B | $4.47B | $4.86B | $3.62B | |
| Total Debt | $9.04B | $6.57B | $6.57B | $7.90B | $6.59B | $7.20B | $6.45B | $6.45B | $4.95B | $4.47B | $4.86B | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.10B | $1.18B | $1.13B | $1.09B | $1.07B | $1.06B | $1.04B | $1.03B | $1.01B | $1.02B | $1.01B | $958M | |
| Retained Earnings | $13.80B | $11.97B | $10.29B | $8.67B | $7.19B | $5.66B | $4.43B | $3.27B | $2.11B | $1.48B | $876M | $709M | |
| Treasury Stock | $10.69B | $7.45B | $5.60B | $4.54B | $2.95B | $2.23B | $2.04B | $1.49B | $852M | $421M | $203M | $0 | |
| AOCI | $-804M | $-940M | $-839M | $-817M | $-764M | $-730M | $-726M | $-629M | $-505M | $-598M | $-622M | $-361M | |
| Stockholders' Equity | $3.42B | $4.77B | $5.00B | $4.41B | $4.54B | $3.77B | $2.71B | $2.19B | $1.79B | $1.50B | $1.07B | $1.31B | |
| Liabilities + Equity | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Shares Outstanding | 424,927,535 | 448,473,073 | 458,367,358 | 463,808,059 | 472,574,090 | 475,317,751 | 475,528,210 | 479,562,326 | 486,130,461 | 492,855,297 | 497,400,113 | 501,327,524 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M | |
| Stock-based Comp | $83M | $74M | $60M | $62M | $58M | $59M | $67M | $53M | $44M | $37M | $43M | $32M | |
| Deferred Tax | $-52M | $-338M | $-61M | $-286M | $-80M | $-62M | $-79M | $-112M | $127M | $-55M | $-85M | $-49M | |
| Amort. of Intangibles | $157M | $170M | $185M | $193M | $204M | $230M | $237M | $157M | $100M | $95M | $64M | $63M | |
| Restructuring | $49M | $43M | $46M | $6M | $33M | $8M | $33M | $26M | $13M | $2M | $301M | $17M | |
| Other Non-cash | $-287M | $234M | $-481M | $-443M | $-250M | $50M | $-105M | $113M | $69M | $-330M | $168M | $-144M | |
| Operating Cash Flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B | $2.13B | $1.79B | $1.79B | $1.35B | $713M | $664M | $626M | |
| CapEx | $621M | $655M | $732M | $586M | $477M | $453M | $460M | $338M | $224M | $216M | $224M | $180M | |
| Investing Cash Flow | $-748M | $-315M | $-777M | $-883M | $-458M | $-572M | $-504M | $-2.26B | $-270M | $-214M | $-1.11B | $-187M | |
| Net Debt Issued | $-1.35B | $0 | $-1.35B | $0 | $-600M | $-500M | $0 | $0 | $-750M | $-400M | · | · | |
| Stock Repurchased | $3.23B | $1.86B | $1.09B | $1.59B | $743M | $250M | $626M | $698M | $500M | $300M | $203M | $0 | |
| Net Stock Activity | $-3.23B | $-1.86B | $-1.09B | $-1.59B | $-743M | $-250M | $-626M | $-698M | $-500M | $-300M | $-203M | · | |
| Financing Cash Flow | $-1.87B | $-2.66B | $-3.11B | $-904M | $-1.86B | $123M | $-951M | $533M | $-251M | $-903M | $755M | $-154M | |
| Net Change in Cash | $325M | $-54M | $-1.54B | $96M | $-119M | $1.67B | $332M | $38M | $837M | $-427M | $272M | $272M | |
| Taxes Paid | $715M | $892M | $754M | $638M | $548M | $418M | $418M | $336M | $455M | $408M | $224M | $278M | |
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B | $1.67B | $1.33B | $1.45B | $1.12B | $497M | $440M | $446M | |
| Levered FCF | $2.11B | $2.12B | $1.43B | $1.15B | $1.55B | $1.48B | $1.15B | $1.28B | $1.02B | $386M | $363M | $362M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% | 7.1% | 12.2% | |
| Pretax Margin | 35.5% | 33.9% | 34.4% | 32.9% | 32.0% | 29.9% | 28.8% | 29.0% | 28.7% | 25.1% | 11.4% | 17.1% | |
| EBITDA Margin | 5.1% | 5.4% | 5.8% | 5.8% | 5.8% | 6.6% | 6.6% | 5.3% | 4.6% | 4.9% | 4.2% | 4.3% | |
| ROA | 18.0% | 17.4% | 16.1% | 14.7% | 14.8% | 13.0% | 13.4% | 14.7% | 10.6% | 10.5% | 4.7% | · | |
| ROE | 66.0% | 50.9% | 49.9% | 47.2% | 49.0% | 50.6% | 58.6% | 66.4% | 52.9% | 64.3% | 28.5% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 | 3.0 | 2.6 | 3.6 | 3.9 | 3.0 | 2.2 | · | |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.9 | 2.3 | 1.5 | 1.2 | · | |
| Debt / Equity | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 | 1.9 | 2.4 | 3.0 | 2.8 | 3.0 | 4.6 | · | |
| LT Debt / Equity | 2.7 | 1.1 | 1.3 | 1.5 | 1.5 | 1.7 | 2.2 | 2.9 | 2.8 | 3.0 | 4.2 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | · | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.2 | 1.1 | 1.3 | · | |
| Receivables Turnover | 6.5 | 7.1 | 6.8 | 6.9 | 7.2 | 6.4 | 5.9 | 5.7 | 5.6 | 5.3 | 5.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.84 | $10.64 | $10.90 | $9.50 | $9.61 | $7.93 | $5.69 | $4.56 | $3.64 | $3.02 | $2.15 | · | |
| Revenue / Share | $21.33 | $20.35 | $18.48 | $17.18 | $16.31 | $13.95 | $12.99 | $11.96 | $10.76 | $9.81 | $9.49 | $9.53 | |
| Cash Flow / Share | $6.54 | $6.49 | $5.09 | $4.06 | $4.64 | $4.44 | $3.73 | $3.68 | $2.73 | $1.43 | $1.32 | $1.25 | |
| Cash / Share | · | · | · | · | · | · | · | · | $3.22 | $1.48 | $2.32 | · | |
| Dividend Paid / Share | $2.03 | $1.80 | $1.56 | $1.35 | $1.07 | $0.85 | $0.69 | $0.54 | $0.44 | $0.39 | $0.34 | $0.30 | |
| EPS (TTM) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.4% | 6.0% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 10.1% | 7.9% | 12.9% | 5.1% | 24.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 10.3% | 8.6% | 14.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 7.5% | 6.1% | 10.9% | 3.8% | 24.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.1% | 6.9% | 12.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Net Income TTM | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| Market Cap | $53.46B | $73.07B | $90.47B | $67.97B | $115.32B | $78.67B | $62.94B | $41.02B | $35.02B | $26.38B | $23.84B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $38.41B | $30.12B | $27.54B | · | |
| P/E | 20.9 | 29.8 | 38.9 | 32.6 | 57.1 | 48.4 | 42.6 | 29.2 | 41.2 | 32.4 | 70.5 | 37.1 | |
| P/S | 5.6 | 7.9 | 10.6 | 8.4 | 14.8 | 11.8 | 10.1 | 7.0 | 6.6 | 5.4 | 5.0 | · | |
| P/B | 16.1 | 15.3 | 18.1 | 15.4 | 25.4 | 20.9 | 23.2 | 18.8 | 19.8 | 17.7 | 22.3 | · | |
| P / Tangible Book | · | 79.5 | 100.5 | 243.6 | 298.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | 18.4 | 24.7 | 38.4 | 35.5 | 52.1 | 37.0 | 35.1 | 22.9 | 26.0 | 37.0 | 35.9 | · | |
| P / FCF | 23.4 | 31.8 | 55.8 | 51.3 | 66.4 | 47.0 | 47.1 | 28.3 | 31.2 | 53.1 | 54.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 158.7 | 125.5 | 138.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 34.2 | 60.6 | 62.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 7.2 | 6.2 | 5.8 | · | |
| Earnings Yield | 4.8% | 3.4% | 2.6% | 3.1% | 1.8% | 2.1% | 2.4% | 3.4% | 2.4% | 3.1% | 1.4% | 2.7% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | $2.20B | $2.32B | $2.39B | $2.36B | $2.19B | $2.21B | $2.15B | $2.18B | $2.00B | $2.04B | $2.00B | |
| Cost of Revenue | $673M | $641M | $712M | $683M | $664M | $618M | $707M | $701M | $668M | $643M | $728M | $638M | $607M | $588M | $653M | $607M | |
| SG&A Expense | $592M | $588M | $619M | $579M | $614M | $574M | $625M | $565M | $581M | $547M | $565M | $525M | $556M | $505M | $514M | $501M | |
| Interest Expense | $61M | $62M | $57M | $58M | $53M | $54M | $51M | $57M | $59M | $58M | $59M | $59M | $58M | $63M | $62M | $53M | |
| Other Non-op | $-2M | $-1M | $-8M | $0 | $-1M | $3M | $1M | $-2M | $2M | $-5M | $5M | $-4M | $2M | $-5M | $6M | $1M | |
| Pretax Income | $866M | $758M | $761M | $887M | $912M | $773M | $732M | $874M | $780M | $747M | $650M | $717M | $872M | $697M | $592M | $667M | |
| Income Tax | $175M | $157M | $158M | $166M | $186M | $171M | $151M | $182M | $156M | $148M | $127M | $121M | $202M | $146M | $132M | $139M | |
| Net Income | $691M | $601M | $603M | $721M | $726M | $602M | $581M | $682M | $624M | $599M | $525M | $596M | $671M | $552M | $461M | $529M | |
| EPS (Basic) | $1.65 | $1.42 | $1.38 | $1.63 | $1.63 | $1.34 | $1.28 | $1.51 | $1.37 | $1.31 | $1.15 | $1.29 | $1.45 | $1.19 | $0.99 | $1.13 | |
| EPS (Diluted) | $1.65 | $1.42 | $1.37 | $1.63 | $1.63 | $1.34 | $1.29 | $1.50 | $1.37 | $1.31 | $1.14 | $1.29 | $1.45 | $1.19 | $0.98 | $1.13 | |
| Shares (Basic) | 417,600,000 | 422,100,000 | · | 442,900,000 | 445,100,000 | 447,600,000 | · | 452,900,000 | 455,500,000 | 458,000,000 | · | 460,300,000 | 461,900,000 | 463,500,000 | · | 467,800,000 | |
| Shares (Diluted) | 417,700,000 | 422,400,000 | · | 443,200,000 | 445,500,000 | 448,000,000 | · | 453,500,000 | 456,000,000 | 458,800,000 | · | 461,400,000 | 462,900,000 | 464,600,000 | · | 469,100,000 | |
| EBITDA | $119M | $119M | · | $124M | $123M | $119M | · | $121M | $127M | $126M | · | $124M | $121M | $120M | · | $115M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.48B | $1.94B | · | $2.08B | $1.44B | $1.72B | · | $1.71B | $1.57B | $1.98B | · | $1.75B | $1.72B | $2.11B | · | $2.51B | |
| Short-term Investments | $200M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $1.57B | $1.51B | $1.59B | $1.54B | $1.54B | $1.36B | $1.32B | $1.41B | $1.38B | $1.29B | · | $1.26B | $1.32B | $1.19B | · | $1.19B | |
| Inventory | $2.57B | $2.55B | $2.43B | $2.46B | $2.44B | $2.37B | $2.31B | $2.42B | $2.45B | $2.65B | · | $2.74B | $2.70B | $2.56B | · | $2.30B | |
| Other Current Assets | $535M | $477M | $436M | $493M | $509M | $430M | $377M | $427M | $467M | $440M | · | $467M | $443M | $411M | · | $552M | |
| Current Assets | $6.36B | $6.47B | $6.77B | $6.58B | $5.92B | $5.88B | $5.99B | $6.28B | $6.20B | $6.36B | · | $6.22B | $6.18B | $6.27B | · | $6.55B | |
| PP&E (Net) | $3.76B | $3.72B | $3.68B | $3.60B | $3.54B | $3.44B | $3.39B | $3.30B | $3.20B | $3.25B | · | $3.09B | $3.01B | $2.91B | · | $2.62B | |
| PP&E (Gross) | · | · | $6.61B | · | · | · | $6.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $3.07B | $3.00B | $2.92B | $2.87B | $2.80B | $2.70B | $2.63B | $2.66B | $2.59B | $2.67B | · | $2.53B | $2.45B | $2.37B | · | $2.23B | |
| Goodwill | $2.77B | $2.78B | $2.77B | $2.76B | $2.76B | $2.72B | $2.72B | $2.74B | $2.74B | $2.76B | $2.76B | $2.76B | $2.71B | $2.74B | $2.75B | $2.69B | |
| Intangibles | $918M | $959M | $998M | $1.04B | $1.07B | $1.08B | $1.13B | $1.19B | $1.23B | $1.29B | · | $1.40B | $1.25B | $1.31B | · | $1.32B | |
| Other Non-current Assets | $384M | $351M | $328M | $293M | $267M | $232M | $250M | $215M | $210M | $227M | · | $216M | $173M | $143M | · | $161M | |
| Total Assets | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Accounts Payable | $452M | $507M | $487M | $410M | $508M | $420M | $433M | $404M | $420M | $405M | · | $388M | $464M | $424M | · | $373M | |
| Accrued Liabilities | · | · | $852M | · | · | · | $746M | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $24M | · | $2M | $2M | $3M | · | $3M | |
| Current Liabilities | $2.06B | $2.05B | $2.23B | $1.81B | $3.37B | $3.38B | $3.41B | $1.70B | $1.80B | $1.91B | · | $1.61B | $1.77B | $1.92B | · | $2.88B | |
| Capital Leases | $190M | $193M | $196M | $204M | $210M | $173M | $174M | $181M | $181M | $184M | · | $191M | $188M | $180M | · | $186M | |
| Deferred Tax | $122M | $130M | $139M | $147M | $156M | $161M | $167M | $172M | $175M | $136M | · | $160M | $121M | $131M | · | $256M | |
| Other Non-current Liabilities | $220M | $219M | $248M | $264M | $274M | $220M | $222M | $220M | $222M | $228M | · | $259M | $217M | $216M | · | $239M | |
| Total Liabilities | $11.93B | $11.92B | $12.14B | $9.76B | $9.50B | $9.44B | $9.47B | $9.12B | $9.21B | $9.30B | · | $9.03B | $9.13B | $9.26B | · | $9.01B | |
| Long-term Debt | · | · | $9.04B | $7.07B | $6.58B | $6.58B | $6.57B | · | · | · | · | $6.55B | $6.55B | $6.56B | · | $6.56B | |
| Total Debt | $9.05B | $9.04B | · | $7.07B | $6.58B | $6.58B | · | $6.57B | $6.56B | $6.59B | · | $6.55B | $6.56B | $6.56B | · | $6.56B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.13B | $1.10B | $1.10B | $1.22B | $1.20B | $1.18B | $1.18B | $1.16B | $1.15B | $1.13B | · | $1.12B | $1.10B | $1.08B | · | $1.07B | |
| Retained Earnings | $14.65B | $14.18B | $13.74B | $13.59B | $12.87B | $12.38B | $11.97B | $11.81B | $11.12B | $10.70B | · | $10.14B | $9.54B | $9.04B | · | $8.53B | |
| Treasury Stock | $11.85B | $11.29B | $10.69B | $8.61B | $8.23B | $7.89B | $7.45B | $6.89B | $6.46B | $5.93B | · | $5.37B | $5.13B | $4.81B | · | $4.14B | |
| AOCI | $-796M | $-772M | $-834M | $-818M | $-877M | $-1.02B | $-940M | $-851M | $-845M | $-841M | · | $-814M | $-895M | $-828M | · | $-809M | |
| Stockholders' Equity | $3.15B | $3.23B | $3.33B | $5.40B | $4.98B | $4.66B | $4.77B | $5.23B | $4.97B | $5.06B | · | $5.08B | $4.62B | $4.49B | · | $4.66B | |
| Liabilities + Equity | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Shares Outstanding | 414,154,046 | 420,348,495 | 424,927,535 | 441,464,339 | 443,945,593 | 446,040,205 | 448,473,073 | 451,549,789 | 453,812,361 | 456,947,205 | · | 459,524,713 | 460,750,652 | 462,495,343 | · | 466,442,095 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $119M | $119M | $121M | $124M | $124M | $119M | $123M | $121M | $127M | $126M | $126M | $124M | $121M | $120M | $119M | $115M | |
| Stock-based Comp | $26M | $25M | $22M | $22M | $22M | $17M | $19M | $18M | $19M | $18M | $17M | $17M | $17M | $9M | $16M | $15M | |
| Deferred Tax | $-33M | $34M | $-48M | $-16M | $-7M | $14M | $-152M | $-42M | $-101M | $-43M | $-21M | $-14M | $-34M | $8M | $-176M | $-34M | |
| Amort. of Intangibles | $38M | $39M | $38M | $39M | $40M | $40M | $42M | $42M | $42M | $44M | $44M | $46M | $48M | $47M | $46M | $48M | |
| Restructuring | $75M | $20M | $16M | $4M | · | · | $-3M | $-2M | $37M | $11M | $8M | $13M | $5M | $20M | $1M | · | |
| Other Non-cash | · | $-378M | · | · | · | $-199M | · | · | · | $-105M | · | · | · | $-140M | · | · | |
| Operating Cash Flow | $655M | $401M | $893M | $938M | $486M | $515M | $905M | $951M | $502M | $595M | $897M | $724M | $183M | $549M | $741M | $526M | |
| CapEx | $117M | $110M | $161M | $133M | $178M | $178M | $216M | $167M | $132M | $140M | $198M | $145M | $166M | $223M | $171M | $154M | |
| Investing Cash Flow | $-300M | $-87M | $-166M | $-160M | $-247M | $-203M | $126M | $-178M | $-132M | $-131M | $-210M | $-271M | $-80M | $-216M | $-438M | $-124M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-1.35B | · | · | |
| Stock Repurchased | $584M | $606M | $2.06B | $394M | $338M | $443M | $553M | $433M | $533M | $339M | $235M | $250M | $324M | $283M | $405M | $377M | |
| Net Stock Activity | · | $-606M | · | · | · | $-443M | · | · | · | $-339M | · | · | · | $-283M | · | · | |
| Financing Cash Flow | $-813M | $-840M | $-495M | $-134M | $-564M | $-677M | $-745M | $-628M | $-763M | $-524M | $-397M | $-416M | $-494M | $-1.80B | $780M | $-529M | |
| Net Change in Cash | $-465M | $-509M | $228M | $649M | $-286M | $-332M | $273M | $140M | $-401M | $-66M | $287M | $37M | $-392M | $-1.47B | $1.07B | $-145M | |
| Taxes Paid | $380M | $50M | $133M | $107M | $428M | $60M | $235M | $176M | $422M | $59M | $168M | $128M | $438M | $20M | $167M | $155M | |
| Free Cash Flow | · | $291M | · | · | · | $438M | · | · | · | $455M | · | · | · | $326M | · | · | |
| Levered FCF | · | $242M | · | · | · | $396M | · | · | · | $408M | · | · | · | $276M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.0% | 26.6% | · | 30.0% | 29.2% | 28.4% | · | 28.6% | 26.4% | 27.4% | · | 27.7% | 30.8% | 27.6% | · | 26.4% | |
| Pretax Margin | 35.1% | 33.5% | · | 37.0% | 36.7% | 36.5% | · | 36.6% | 33.0% | 34.1% | · | 33.3% | 40.0% | 34.8% | · | 33.3% | |
| EBITDA Margin | 4.8% | 5.3% | · | 5.2% | 5.0% | 5.4% | · | 5.1% | 5.4% | 5.8% | · | 5.8% | 5.5% | 6.0% | · | 5.7% | |
| ROA | 4.7% | 4.1% | · | 4.9% | 5.0% | 4.4% | · | 4.8% | 4.5% | 4.3% | · | 4.3% | 4.9% | 4.0% | · | 3.9% | |
| ROE | 17.0% | 15.2% | · | 13.6% | 14.4% | 13.0% | · | 13.2% | 13.0% | 12.5% | · | 12.2% | 14.6% | 12.1% | · | 11.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 3.2 | · | 3.6 | 1.8 | 1.7 | · | 3.7 | 3.5 | 3.3 | · | 3.9 | 3.5 | 3.3 | · | 2.3 | |
| Quick Ratio | 1.6 | 1.7 | · | 2.0 | 0.9 | 0.9 | · | 1.8 | 1.6 | 1.7 | · | 1.9 | 1.7 | 1.7 | · | 1.3 | |
| Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.4 | |
| LT Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.1 | 1.1 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.7 | · | 1.8 | 1.7 | 1.8 | · | 1.8 | 1.7 | 1.7 | · | 1.7 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.60 | $7.69 | · | $12.23 | $11.21 | $10.44 | · | $11.59 | $10.94 | $11.07 | · | $11.05 | $10.04 | $9.72 | · | $10.00 | |
| Revenue / Share | $5.91 | $5.36 | · | $5.42 | $5.52 | $4.96 | · | $5.27 | $5.18 | $4.77 | · | $4.66 | $4.71 | $4.30 | · | $4.27 | |
| Cash Flow / Share | · | $0.95 | · | · | · | $1.31 | · | · | · | $1.30 | · | · | · | $1.18 | · | · | |
| Cash / Share | $3.56 | $4.62 | · | $4.72 | $3.23 | $3.86 | · | $3.80 | $3.47 | $4.32 | · | $3.82 | $3.73 | $4.56 | · | $5.37 | |
| Dividend / Share | $0.53 | $0.53 | · | $0.00 | $0.50 | $0.50 | · | $0.00 | $0.43 | $0.43 | · | $0.00 | $0.38 | $0.38 | · | $0.00 | |
| EPS (TTM) | $6.07 | $6.05 | · | $5.89 | $5.76 | $5.50 | · | $5.32 | $5.11 | $5.19 | · | $4.91 | $4.75 | $4.42 | · | $4.38 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.52B | $9.52B | · | $9.39B | $9.38B | $9.26B | · | $9.15B | $8.91B | $8.73B | · | $8.37B | $8.22B | $8.09B | · | $8.01B | |
| Net Income TTM | $2.62B | $2.65B | · | $2.63B | $2.59B | $2.49B | · | $2.43B | $2.34B | $2.39B | · | $2.28B | $2.21B | $2.07B | · | $2.07B | |
| Market Cap | $29.76B | $49.69B | · | $64.60B | $69.23B | $73.44B | · | $88.22B | $78.67B | $77.32B | · | $79.95B | $79.35B | $76.98B | · | $69.17B | |
| Enterprise Value | $37.13B | $56.79B | · | $69.58B | $74.38B | $78.30B | · | $93.08B | $83.66B | $81.93B | · | $84.75B | $84.19B | $81.43B | · | $73.22B | |
| P/E | 11.8 | 19.5 | · | 24.8 | 27.1 | 29.9 | · | 36.7 | 33.9 | 32.6 | · | 35.4 | 36.3 | 37.7 | · | 33.9 | |
| P/S | 3.1 | 5.2 | · | 6.9 | 7.4 | 7.9 | · | 9.6 | 8.8 | 8.9 | · | 9.6 | 9.7 | 9.5 | · | 8.6 | |
| P/B | 9.5 | 15.4 | · | 12.0 | 13.9 | 15.8 | · | 16.9 | 15.8 | 15.3 | · | 15.7 | 17.2 | 17.1 | · | 14.8 | |
| P / Tangible Book | · | · | · | 40.5 | 60.5 | 85.7 | · | 67.7 | 78.6 | 77.0 | · | 87.1 | 120.4 | 174.2 | · | 106.1 | |
| P / Cash Flow | · | 123.9 | · | · | · | 125.1 | · | · | · | 129.9 | · | · | · | 140.2 | · | · | |
| EV / Revenue | 3.9 | 6.0 | · | 7.4 | 7.9 | 8.5 | · | 10.2 | 9.4 | 9.4 | · | 10.1 | 10.2 | 10.1 | · | 9.1 | |
| Earnings Yield | 8.5% | 5.1% | · | 4.0% | 3.7% | 3.3% | · | 2.7% | 2.9% | 3.1% | · | 2.8% | 2.8% | 2.7% | · | 2.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Nettoergebnis | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| Verwässerte EPS | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 |
| Liquiditätsgrad | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
Institutionelle Eigentümer (13F) 1.578 Einreicher · $35.8B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
1.578
Gehaltener Wert
$35.8B
Neue Positionen
170
Geschlossene Positionen
318
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 170 (-31 vs. Vorquartal) | 318 (+136 vs. Vorquartal) | 521 (-88 vs. Vorquartal) | 585 (-42 vs. Vorquartal) | -6.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6.011.802.148 | 47.780.974 | 16,82% | Aktien |
| BlackRock, Inc. | $2.833.452.809 | 39.430.181 | 7,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.870.370.930 | 26.027.984 | 5,23% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.714.611.578 | 23.860.445 | 4,80% | Aktien |
| STATE STREET CORP | $1.413.322.575 | 19.667.723 | 3,95% | Aktien |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1.142.064.009 | 15.892.903 | 3,19% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $951.789.721 | 13.289.622 | 2,66% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $677.201.094 | 9.423.895 | 1,89% | Aktien |
| MORGAN STANLEY | $638.034.469 | 8.878.849 | 1,78% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $519.929.070 | 4.398.351 | 1,45% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $471.698.956 | 6.592.578 | 1,32% | Aktien |
| JANUS HENDERSON GROUP PLC | $437.568.419 | 3.701.747 | 1,22% | Aktien |
| DEUTSCHE BANK AG\ | $420.505.821 | 5.851.737 | 1,18% | Aktien |
| NORTHERN TRUST CORP | $398.264.934 | 5.542.234 | 1,11% | Aktien |
| Invesco Ltd. | $396.884.095 | 5.523.018 | 1,11% | Aktien |
| FIL Ltd | $386.734.926 | 5.381.783 | 1,08% | Aktien |
| NORGES BANK | $337.012.405 | 4.689.847 | 0,94% | Aktien |
| VAN ECK ASSOCIATES CORP | $305.558.780 | 4.252.140 | 0,85% | Aktien |
| FLOSSBACH VON STORCH SE | $302.600.879 | 4.210.978 | 0,85% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $287.726.761 | 4.003.981 | 0,80% | Aktien |
| Amundi | $286.622.090 | 3.988.618 | 0,80% | Aktien |
| BANK OF AMERICA CORP /DE/ | $282.045.207 | 3.924.926 | 0,79% | Aktien |
| UBS Group AG | $261.803.299 | 3.643.241 | 0,73% | Aktien |
| Legal & General Group Plc | $256.352.499 | 3.567.388 | 0,72% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $255.637.351 | 3.557.436 | 0,72% | Aktien |
| CIBC Private Wealth Group LLC | $246.008.713 | 1.681.306 | 0,69% | Aktien |
| Bank of New York Mellon Corp | $238.741.846 | 3.322.319 | 0,67% | Aktien |
| GOLDMAN SACHS GROUP INC | $229.937.577 | 3.199.799 | 0,64% | Aktien |
| CITADEL ADVISORS LLC | $229.108.579 | 3.188.263 | 0,64% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $225.456.582 | 3.137.442 | 0,63% | Aktien |
| JPMORGAN CHASE & CO | $192.268.534 | 2.624.825 | 0,54% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $173.617.784 | 2.416.056 | 0,49% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $170.008.975 | 2.365.836 | 0,48% | Aktien |
| Ruane, Cunniff & Goldfarb L.P. | $169.108.138 | 2.353.300 | 0,47% | Aktien |
| BARCLAYS PLC | $165.474.682 | 2.302.737 | 0,46% | Aktien |
| Qube Research & Technologies Ltd | $163.792.869 | 2.279.333 | 0,46% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $156.216.242 | 2.173.278 | 0,44% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $152.540.744 | 2.122.749 | 0,43% | Aktien |
| JANE STREET GROUP, LLC | $144.534.676 | 2.011.337 | 0,40% | Aktien |
| BRANDES INVESTMENT PARTNERS, LP | $138.737.455 | 1.930.651 | 0,39% | Aktien |
| HSBC HOLDINGS PLC | $132.131.854 | 1.839.811 | 0,37% | Aktien |
| BLS Capital Fondsmaeglerselskab A/S | $131.538.868 | 1.830.488 | 0,37% | Aktien |
| ROYAL BANK OF CANADA | $131.385.000 | 1.828.326 | 0,37% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $130.336.722 | 1.813.759 | 0,36% | Aktien |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $130.169.165 | 1.864.087 | 0,36% | Aktien |
| WELLS FARGO & COMPANY/MN | $130.014.751 | 1.809.278 | 0,36% | Aktien |
| Man Group plc | $129.707.516 | 1.805.003 | 0,36% | Aktien |
| Nuveen, LLC | $129.322.602 | 1.799.647 | 0,36% | Aktien |
| BANQUE PICTET & CIE SA | $128.888.455 | 1.793.605 | 0,36% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $125.134.922 | 1.741.371 | 0,35% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×7 Einreichungen | 8. Juli 2016 | · | Erste Einreichung | · | SEC |
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 Einreichungen | 4. Februar 2015 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 52 Insider · 30 Führungskräfte · 21 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kristin C Peck | Chief Executive Officer | 10. Juli 2026 A | 105.068 | 0 | 2 | $-2.540.972 |
| James Saccaro | EVP, CFO & COO | 31. August 2026 A | · | 0 | 0 | $0 |
| Wetteny Joseph | Chief Financial Officer | 10. Juli 2026 A | 22.113 | 0 | 0 | $0 |
| Paul Herendeen | Exec. V.P. and CFO | 19. Juli 2016 A | · | 0 | 0 | $0 |
| Julie Fuller | Executive Vice President | 30. September 2026 M | 1.588 | 0 | 0 | $0 |
| Kevin Esch | Executive Vice President | 10. Juli 2026 A | 578 | 0 | 0 | $0 |
| Keith Sarbaugh | Executive Vice President | 10. Juli 2026 A | 3.346 | 0 | 0 | $0 |
| Rimma Driscoll | Executive Vice President | 10. Juli 2026 A | 5.715 | 0 | 0 | $0 |
| Astorga Jeannette Ferran | Executive Vice President | 10. Juli 2026 A | 1.684 | 0 | 0 | $0 |
| Abhay U Nayak | Executive Vice President | 10. Juli 2026 A | 1.965 | 0 | 0 | $0 |
| Roxanne Lagano | Executive Vice President | 10. Juli 2026 A | 15.632 | 0 | 0 | $0 |
| Jamie Brannan | Executive Vice President | 19. Februar 2026 M | 3.290 | 0 | 0 | $0 |
| Nicholas Ashton | Executive Vice President | 19. Februar 2026 M | 1.822 | 0 | 0 | $0 |
| Robert J Polzer | Executive Vice President | 10. Oktober 2025 A | 5.120 | 0 | 0 | $0 |
| Soria Ester Banque | Executive Vice President | 4. Oktober 2024 A | 588 | 0 | 0 | $0 |
| Wafaa Mamilli | Executive Vice President | 4. Oktober 2024 A | 6.685 | 0 | 0 | $0 |
| Heidi C. Chen | Executive Vice President | 5. April 2024 A | 31.293 | 0 | 0 | $0 |
| Glenn David | Executive Vice President | 13. Januar 2023 A | 46.572 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President | 7. Oktober 2022 A | · | 0 | 0 | $0 |
| Roman Trawicki | Executive Vice President | 16. März 2022 M | 8.218 | 0 | 0 | $0 |
| Catherine A. Knupp | Executive Vice President | 10. November 2021 S | 43.642 | 0 | 0 | $0 |
| Sherry N Pudloski | Executive Vice President | 8. Oktober 2021 A | · | 0 | 0 | $0 |
| Robert Edward Kelly | Executive Vice President | 3. Mai 2021 M | 8.300 | 0 | 0 | $0 |
| James Michael Mcfarland | Executive Vice President | 9. April 2021 A | 2.547 | 0 | 0 | $0 |
| Clinton A. Lewis Jr. | Executive Vice President | 16. Dezember 2019 M | 27.904 | 0 | 0 | $0 |
| Andrew Fenton | Executive Vice President | 6. Dezember 2019 M | 23.073 | 0 | 0 | $0 |
| Alejandro Bernal | Executive Vice President | 27. Februar 2018 M | 11.417 | 0 | 0 | $0 |
| Sandra J. Beaty | Executive Vice President | 30. April 2015 A | 6.721 | 0 | 0 | $0 |
| Joyce J. Lee | Executive Vice President | 9. April 2015 A | 3.838 | 0 | 0 | $0 |
| Stefan Weiskopf | Executive Vice President | 27. Februar 2015 A | 3.658 | 0 | 0 | $0 |
| Mark Stetter | Direktor | 17. September 2026 A | 1.572 | 0 | 0 | $0 |
| Frank A Damelio | Direktor | 7. August 2026 G | 14.808 | 1 | 0 | $501.344 |
| Michael B Mccallister | Direktor | 10. Juni 2026 G | 0 | 1 | 0 | $233.280 |
| Louise M Parent | Direktor | 20. Mai 2026 M | 28.394 | 0 | 0 | $0 |
| Paul Bisaro | Direktor | 13. Mai 2026 P | 27.862 | 1 | 0 | $151.760 |
| Gregory Norden | Direktor | 9. März 2026 G | 0 | 0 | 0 | $0 |
| Vanessa Broadhurst | Direktor | 19. Februar 2026 M | 3.920 | 0 | 0 | $0 |
| Antoinette Renee Leatherberry | Direktor | 19. Februar 2026 M | 5.280 | 0 | 0 | $0 |
| Willie M Reed | Direktor | 19. Februar 2026 M | 12.864 | 0 | 0 | $0 |
| Gavin Hattersley | Direktor | 19. Februar 2026 M | 3.354 | 0 | 0 | $0 |
| Khosla Sanjay | Direktor | 19. Februar 2026 A | 1.892 | 0 | 0 | $0 |
| Stephanie Tilenius | Direktor | 18. Februar 2026 A | · | 0 | 0 | $0 |
| Robert W Scully | Direktor | 21. Mai 2025 M | 21.489 | 0 | 0 | $0 |
| Linda Rhodes | Direktor | 21. Mai 2024 M | 11.192 | 0 | 0 | $0 |
| Juan Ramon Alaix | Direktor | 20. Mai 2021 D | 215.129 | 0 | 0 | $0 |
| William C Steere JR | Direktor | 20. Mai 2021 M | 35.074 | 0 | 0 | $0 |
| Charles H Hill | Direktor | 6. Februar 2013 P | 5.000 | 0 | 0 | $0 |
| Amy Schulman | Direktor | 6. Februar 2013 P | 5.000 | 0 | 0 | $0 |
| Douglas E. Giordano | Direktor | 6. Februar 2013 P | 5.000 | 0 | 0 | $0 |
| Geno J Germano | Direktor | 6. Februar 2013 P | 5.000 | 0 | 0 | $0 |
| Pfizer Inc. | 10%-Eigentümer | 24. Juni 2013 C | 0 | 0 | 0 | $0 |
| Richard A. Passov | · | 15. Juli 2014 A | 3.706 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 154 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHE · iShares Trust | 3,78% | 840.871 SH | 11. September 2026 | Täglich |
| SMRI · EA Series Trust | 1,83% | 152.486 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,82% | 246.575 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,56% | 196.180 SH | 2. Oktober 2026 | Täglich |
| CZA · Invesco Exchange-Traded Fund Trust | 1,54% | 45.027 SH | 2. Oktober 2026 | Täglich |
| CVAR · ETF Opportunities Trust | 1,40% | 7.761 NS | 31. Juli 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,08% | 2.889 NS | 31. Juli 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,91% | 220.756 SH | 2. Oktober 2026 | Täglich |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,74% | 17.243 NS | 31. Juli 2026 | N-PORT |
| IWP · iShares Trust | 0,71% | 1.867.940 SH | 11. September 2026 | Täglich |
| COWZ · Pacer Funds Trust | 0,62% | 1.502.929 NS | 31. Juli 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,59% | 2.890.747 SH | 19. August 2026 | Täglich |
| FLAG · Global X Funds | 0,56% | 123 NS | 31. Juli 2026 | N-PORT |
| ESLV · Strategy Shares | 0,52% | 951 NS | 31. Juli 2026 | N-PORT |
| PABU · iShares Trust | 0,51% | 174.679 SH | 11. September 2026 | Täglich |
| IYH · iShares Trust | 0,49% | 246.300 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,47% | 200.057 NS | 31. Juli 2026 | N-PORT |
| RCGE · EA Series Trust | 0,47% | 6.141 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,45% | 1.264.118 SH | 19. August 2026 | Täglich |
| IXJ · iShares Trust | 0,39% | 219.915 SH | 10. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,37% | 8.250 NS | 31. Juli 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0,35% | 3.218 NS | 31. Juli 2026 | N-PORT |
| ESUM · Strategy Shares | 0,33% | 7.829 NS | 31. Juli 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0,31% | 57.270 NS | 31. Juli 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,31% | 10.926.000 | 2. Oktober 2026 | Täglich |
| SUSA · iShares Trust | 0,30% | 164.110 SH | 11. September 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,29% | 33.789 SH | 19. August 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,28% | 212.600 NS | 31. Juli 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,28% | 754.566 SH | 2. Oktober 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,26% | 8.177.172 SH | 19. August 2026 | Täglich |
| EVUS · iShares Trust | 0,25% | 13.282 SH | 11. September 2026 | Täglich |
| IMCV · iShares Trust | 0,25% | 39.931 SH | 11. September 2026 | Täglich |
| DUHP · Dimensional ETF Trust | 0,24% | 375.907 NS | 31. Juli 2026 | N-PORT |
| QDF · FlexShares Trust | 0,23% | 67.413 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,23% | 1.725.551 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,21% | 49.261 SH | 11. September 2026 | Täglich |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 206.683 NS | 31. Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 50.884 SH | 11. September 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 2.662.408 SH | 2. Oktober 2026 | Täglich |
| LRND · New York Life Investments ETF Trust | 0,18% | 9.465 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,18% | 5.589.000 | 2. Oktober 2026 | Täglich |
| DGRO · iShares Trust | 0,18% | 1.051.645 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,18% | 97.153 SH | 11. September 2026 | Täglich |
| SIZE · iShares Trust | 0,18% | 10.276 SH | 11. September 2026 | Täglich |
| XOEF · iShares Trust | 0,17% | 526 SH | 11. September 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,17% | 7.884.000 | 2. Oktober 2026 | Täglich |
| LCOW · Pacer Funds Trust | 0,16% | 529 NS | 31. Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,15% | 25.943 NS | 31. Juli 2026 | N-PORT |
| ESGU · iShares Trust | 0,15% | 364.501 SH | 10. September 2026 | Täglich |
| ESMV · iShares Trust | 0,15% | 158 SH | 10. September 2026 | Täglich |
| GSY · Invesco Actively Managed Exchange-T… | 0,15% | 5.769.000 | 2. Oktober 2026 | Täglich |
| PALC · Pacer Funds Trust | 0,15% | 3.973 NS | 31. Juli 2026 | N-PORT |
| QUAL · iShares Trust | 0,14% | 888.569 SH | 11. September 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,13% | 175.000 | 2. Oktober 2026 | Täglich |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,13% | 2.368.421 SH | 19. August 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,13% | 1.680.027 SH | 19. August 2026 | Täglich |
| NUDV · Nushares ETF Trust | 0,13% | 834 NS | 31. Juli 2026 | N-PORT |
| USXF · iShares Trust | 0,12% | 24.978 SH | 11. September 2026 | Täglich |
| ESG · FlexShares Trust | 0,12% | 2.010 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 6.837 NS | 31. Juli 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0,11% | 11.940 SH | 2. Oktober 2026 | Täglich |
| IVE · iShares Trust | 0,10% | 695.597 SH | 11. September 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 14.085 SH | 2. Oktober 2026 | Täglich |
| IQSU · New York Life Investments ETF Trust | 0,10% | 4.253 NS | 31. Juli 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,10% | 3.598.101 SH | 19. August 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,10% | 96.479 SH | 19. August 2026 | Täglich |
| CHRI · Global X Funds | 0,10% | 102 NS | 31. Juli 2026 | N-PORT |
| LGDX · Tidal Trust III | 0,10% | 1.814 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,10% | 368.059 SH | 11. September 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,09% | 3.986 NS | 31. Juli 2026 | N-PORT |
| SUSL · iShares Trust | 0,09% | 14.854 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 10.375 SH | 2. Oktober 2026 | Täglich |
| DSI · iShares Trust | 0,09% | 64.531 SH | 11. September 2026 | Täglich |
| HAPI · Harbor ETF Trust | 0,08% | 5.320 NS | 31. Juli 2026 | N-PORT |
| AQLT · iShares Trust | 0,08% | 3.693 SH | 10. September 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,08% | 55.415 SH | 2. Oktober 2026 | Täglich |
| WRND · New York Life Investments ETF Trust | 0,08% | 109 NS | 31. Juli 2026 | N-PORT |
| MPLY · Strategy Shares | 0,08% | 158 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,08% | 5.377 NS | 31. Juli 2026 | N-PORT |
| ESGG · FlexShares Trust | 0,07% | 1.064 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,07% | 21 NS | 31. Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,07% | 1.245.265 SH | 11. September 2026 | Täglich |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 521.663 SH | 19. August 2026 | Täglich |
| IWS · iShares Trust | 0,06% | 135.157 SH | 11. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 85.655 SH | 2. Oktober 2026 | Täglich |
| CRBN · iShares Trust | 0,06% | 9.378 SH | 10. September 2026 | Täglich |
| TOPC · iShares Trust | 0,06% | 258 SH | 11. September 2026 | Täglich |
| ACVF · ETF Opportunities Trust | 0,06% | 1.125 NS | 31. Juli 2026 | N-PORT |
| USCL · iShares Trust | 0,06% | 22.073 SH | 10. September 2026 | Täglich |
| HQGO · Lattice Strategies Trust | 0,06% | 354 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,05% | 34 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,05% | 452 NS | 31. Juli 2026 | N-PORT |
| XRMI · Global X Funds | 0,05% | 344 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,05% | 4.833 SH | 10. September 2026 | Täglich |
| XCLR · Global X Funds | 0,05% | 24 NS | 31. Juli 2026 | N-PORT |
| ILCV · iShares Trust | 0,05% | 9.460 SH | 11. September 2026 | Täglich |
| PTLC · Pacer Funds Trust | 0,05% | 21.352 NS | 31. Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 57.993 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 7.112 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,05% | 21.020 NS | 31. Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,05% | 10.888.932 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,05% | 95.134 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,05% | 1.758 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 34.718 NS | 31. Juli 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,05% | 36 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 5.283.923 SH | 11. September 2026 | Täglich |
| ILCB · iShares Trust | 0,05% | 8.221 SH | 9. September 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1.582 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,05% | 64.661 SH | 2. Oktober 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,05% | 10.102 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 70.832 NS | 31. Juli 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,04% | 72.658 SH | 2. Oktober 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,04% | 2.457 SH | 2. Oktober 2026 | Täglich |
| IYY · iShares Trust | 0,04% | 18.056 SH | 10. September 2026 | Täglich |
| IWB · iShares Trust | 0,04% | 290.521 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,04% | 115.640 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,04% | 544.118 SH | 11. September 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,04% | 9.810 SH | 2. Oktober 2026 | Täglich |
| ILCG · iShares Trust | 0,04% | 17.162 SH | 11. September 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,04% | 440.643 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 11.984.400 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 69.366 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 35.465 SH | 19. August 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2.917 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,04% | 17.007 NS | 31. Juli 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,04% | 32.772 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 1.209 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 325 SH | 2. Oktober 2026 | Täglich |
| URTH · iShares, Inc. | 0,03% | 37.976 SH | 10. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,03% | 9.950 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 138.514 SH | 9. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 356.907 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 8.216 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 69.465 NS | 31. Juli 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,02% | 2.228 NS | 31. Juli 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,02% | 5.737 NS | 31. Juli 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 54.015 SH | 19. August 2026 | Täglich |
| IWD · iShares Trust | 0,02% | 198.738 SH | 11. September 2026 | Täglich |
| QDEF · FlexShares Trust | 0,02% | 1.148 NS | 31. Juli 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 3.000 | 30. September 2026 | Täglich |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 66.000 | 2. Oktober 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 6.792 NS | 31. Juli 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
ZTS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 24 Analysten
KAUF
Median-Ziel
$89.50
+28,4%
4 16,7%
Starker Kauf
8 33,3%
Kauf
12 50,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
14 Analysten · 2026-09-28Mittelwert-Ziel $96.00 +37,8%
← Unter allen Zielen
Aktueller Preis $69.69
Tief$80.00
Mittelwert$96.00
Hoch$155.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Zoetis Aktie: Analystenschätzungen & Ratings
Yahoo Finance · 4 Monate, 2 Wochen vor
Dieser Tiergesundheit Aktien ist mit seinem niedrigsten P/E-Verhältnis jemals geführend
Nasdaq · 5 Monate, 1 Woche vor
2 Healthcare Aktien zum Kaufen und 1, bei der man vorsichtig sein sollte
Nasdaq · 5 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026